Adverum Biotechnologies (ADVM)
NASDAQ:ADVM

Adverum Biotechnologies (ADVM) Similar Stocks

561 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Adverum Biotechnologies
$163.36M
-0.77
-54.77%
5 Buy
1 Hold
0 Sell
Strong Buy
$27.60
Fate Therapeutics
$589.65M
-2.70
26.46%
5 Buy
8 Hold
0 Sell
Moderate Buy
$6.55
Crispr Therapeutics AG
$4.70B
-20.35
0.51%
9 Buy
6 Hold
2 Sell
Moderate Buy
$75.13
Editas Medicine
$439.15M
-2.54
-36.56%
3 Buy
7 Hold
0 Sell
Moderate Buy
$11.50
Intellia Therapeutics
$2.47B
-4.77
-38.12%
15 Buy
4 Hold
0 Sell
Strong Buy
$59.73

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
ADVM
Adverum Biotechnologies
8.09
-11.61
-58.93%
FATE
Fate Therapeutics
5.40
1.13
26.46%
CRSP
Crispr Therapeutics AG
57.57
0.29
0.51%
EDIT
Editas Medicine
5.57
-3.21
-36.56%
NTLA
Intellia Therapeutics
26.42
-15.56
-37.07%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis